Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Apr 30, 2025 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | (Q3)Jan 31, 2023 | (Q2)Oct 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.35%21.6B | 8.29%20.9B | 5.19%6.84B | -5.15%4.07B | 12.87%5.49B | 23.57%4.49B | 5.04%19.3B | -0.59%6.51B | 4.57%4.29B | 22.47%4.87B |
| Cost of revenue | 2.59%17.43B | 8.61%16.99B | 5.02%5.53B | -4.73%3.42B | 12.54%4.41B | 26.51%3.63B | 6.00%15.65B | 0.24%5.27B | 9.10%3.59B | 21.20%3.92B |
| Gross profit | 6.66%4.17B | 6.90%3.91B | 5.92%1.31B | -7.30%653.27M | 14.21%1.09B | 12.52%859.02M | 1.12%3.65B | -3.98%1.24B | -13.68%704.72M | 28.03%950.18M |
| Operating expense | 0.33%3.49B | 2.86%3.48B | 3.90%888M | -0.13%798.59M | 8.63%874.75M | -0.56%914M | 4.16%3.38B | -10.68%854.68M | 4.64%799.64M | 4.54%805.26M |
| Operating profit | 57.66%680.07M | 56.48%431.36M | 10.44%421.23M | -53.09%-145.32M | 45.21%210.42M | 64.69%-54.98M | -25.50%275.67M | 15.45%381.4M | -281.85%-94.92M | 615.15%144.91M |
| Net non-operating interest income (expenses) | -72.12%-112.74M | -8.58%-65.5M | -29.12%-18.37M | -11.02%-16.41M | 1.53%-16.06M | 2.32%-14.66M | -21.32%-60.33M | 1.56%-14.23M | -23.10%-14.78M | -26.50%-16.31M |
| Non-operating interest income | -14.68%18.34M | 8.68%21.5M | -1.75%4.05M | 7.26%6.17M | 44.81%5.55M | -5.72%5.72M | 14.19%19.78M | 3.07%4.13M | 14.78%5.76M | 7.52%3.83M |
| Non-operating interest expense | 50.67%131.08M | 8.60%86.99M | 22.18%22.43M | 9.97%22.58M | 7.29%21.61M | -3.30%20.38M | 19.48%80.1M | -0.55%18.36M | 20.65%20.53M | 22.38%20.14M |
| Net investment income | -100.35%-792K | 80.00%229.51M | 111.59%8.52M | 6.93%48.95M | -24.82%63M | 52.55%109.04M | -34.07%127.51M | -162.77%-73.55M | 74.87%45.78M | 177.18%83.8M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 17.05M | 0 | ||||||||
| Income from associates and other participating interests | -1,114.01%-25.7M | -90.98%2.53M | -51.74%10.51M | -26.85%-34.72M | 390.05%18.34M | -79.00%8.4M | 144.63%28.09M | 23.96%21.78M | 2.66%-27.38M | 75.25%-6.32M |
| Special income (charges) | -59.71%67.45M | 140.57%167.39M | 119.19%62.14M | -5.6M | 93.36%-2.45M | 318.61%113.31M | -538.80%-412.64M | -265.17%-323.82M | 0 | -36.98M |
| Less:Impairment of capital assets | ---- | --0 | --0 | ---- | ---- | --0 | 148.93%92.46M | --0 | --0 | --36.98M |
| Less:Other special charges | 59.71%-67.45M | -187.01%-167.39M | -13.64%-62.14M | --5.6M | --2.45M | -3,008.64%-113.31M | -35.50%-58.32M | -188.37%-54.68M | --0 | --0 |
| Less:Write off | ---- | --0 | ---- | ---- | ---- | ---- | 436.92%378.5M | ---- | ---- | ---- |
| Other non-operating income (expenses) | 242.39%219.87M | -54.73%64.22M | 120.79%16.52M | -45.49%10.83M | 1,452.06%33.84M | -97.42%3.02M | 143.26%141.86M | 122.56%7.48M | -66.20%19.88M | -104.39%-2.5M |
| Income before tax | 1.89%845.21M | 728.17%829.51M | 53,407.03%500.55M | -99.19%-142.26M | 84.34%307.1M | 2,669.09%164.12M | -77.21%100.16M | -100.29%-939K | -173.59%-71.42M | 706.47%166.59M |
| Income tax | 14.27%318.24M | 595.90%278.49M | 3,791.07%121.52M | -21.69%-15.8M | 24.96%77.72M | 871.65%95.05M | -83.56%40.02M | -97.68%3.12M | -126.38%-12.98M | 87.67%62.2M |
| Net income | -4.36%526.97M | 816.20%551.01M | 9,428.94%379.04M | -116.41%-126.47M | 119.71%229.37M | 278.56%69.07M | -69.33%60.14M | -102.15%-4.06M | -222.18%-58.44M | 936.45%104.4M |
| Net income continuous operations | -4.36%526.97M | 816.19%551.01M | 9,431.24%379.04M | -116.41%-126.47M | 119.71%229.37M | 278.58%69.07M | -69.33%60.14M | -102.14%-4.06M | -222.17%-58.44M | 936.32%104.4M |
| Noncontrolling interests | -289.45%-7.79M | -56.01%4.11M | -61.95%2.18M | -149.84%-1.28M | 127.38%244K | 52.44%2.97M | 67.48%9.35M | 219.71%5.73M | 3.42%2.57M | -162.66%-891K |
| Net income attributable to the company | -2.22%534.76M | 976.81%546.9M | 3,950.18%376.86M | -105.20%-125.19M | 117.62%229.13M | 305.62%66.1M | -73.34%50.79M | -105.22%-9.79M | -234.53%-61.01M | 857.26%105.29M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -2.22%534.76M | 976.81%546.9M | 3,950.18%376.86M | -105.20%-125.19M | 117.62%229.13M | 305.62%66.1M | -73.34%50.79M | -105.22%-9.79M | -234.53%-61.01M | 857.26%105.29M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -2.21%206.21 | 977.02%210.88 | 3,944.18%145.31 | -105.23%-48.27 | 117.61%88.35 | 305.89%25.49 | -73.34%19.58 | -105.23%-3.78 | -234.55%-23.52 | 857.46%40.6 |
| Diluted earnings per share | -2.21%206.21 | 977.02%210.88 | 3,944.18%145.31 | -105.20%-48.2718 | 117.62%88.35 | 305.89%25.49 | -73.34%19.58 | -105.23%-3.78 | -234.58%-23.5243 | 857.26%40.5988 |
| Dividend per share | 0.00%50 | 0.00%50 | 0.00%50 | 0 | 0 | 0 | 0.00%50 | 0.00%50 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |